by H.S. Ayoub
BioHealth Investor.com
Biotechnology
DISCOVERY LABS INC [DSCO] +13.13%
ACCENTIA BIOPHARMACE [ABPI] +9.20%
DENDREON CORP [DNDN] +7.58%
ARIAD PHARM INC [ARIA] +6.29%
VERNALIS PLC ADR [VNLS] +6.25%
Diagnostic Substances
SYNOVICS PHARMACEUTL [SYVC.OB] +11.11%
PRESSURE BIOSCIENC [PBIO] +9.89%
ROSETTA GENOMICS LTD [ROSG] +7.50%
MERIDIAN BIOSCIENC [VIVO] +2.49%
MYRIAD GENETICS [MYGN] +2.11%
Drug Delivery
BENTLEY PHARMACEUTIC [BNT] +8.90%
COLUMBIA LABS INC [CBRX] +8.16%
BIOPROGRESS PLC [BPRG] +3.35%
SKYEPHARMA PLC [SKYE] +2.09%
ELAN CP PLC ADR [ELN] +0.86%
Drug Manufacturers
MARSHALL EDWARDS [MSHL] +7.95%
REGENERX BIOPHARM IN [RGN] +6.82%
DEPOMED INC [DEPO] +5.52%
SIGA TECH INC [SIGA] +4.87%
ANGIOTECH PHARMA I [ANPI] +4.77%
Drug Related Products
XELR8 HOLDINGS, INC [BZI] +6.82%
DRAXIS HEALTH INC [DRAX] +3.69%
PRESTIGE BRAND HLGS [PBH] +1.23%
Generic Drugs
WATSON PHARMACEUTCLS [WPI] +8.13%
CATALYST PHARMACEUTI [CPRX] +1.79%
MYLAN LABS INC [MYL] +1.00%
PHARMACUTICAL CO [PRX] +1.00%
HI-TECH PHARMACAL [HITK] +0.83%
Medical Appliances & Equipment
ENDOCARE INC [ENDO.OB] +10.26%
SPECTRASCIENCE NEW [SCIE.OB] +7.50%
WRIGHT MEDICAL GRO [WMGI] +6.69%
SPAN AMERICA MED S [SPAN] +5.71%
CAMBRIDGE HEART INC [CAMH.OB] +5.68%
Medical Instruments & Supplies
SONOSITE INC [SONO] +10.25%
DENTSPLY INTL INC [XRAY] +8.80%
BIOJECT MEDICAL [BJCT] +4.76%
VASCULAR SOLUTIONS [VASC] +4.53%
BOSTON SCIENTIFIC CP [BSX] +3.47%
Medical Laboratories & Research
GENOMIC HEALTH, INC. [GHDX] +4.54%
NEOGENOMICS INC [NGNM.OB] +3.23%
MEDTOX SCIENTFIC INC [MTOX] +1.45%
OSI PHARMACEUTIC [OSIP] +1.27%
BIO-REFERENCE LAB [BRLI] +0.48%
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.